Some studies have reported that T2DM, characterized by insulin resistance, resulted to chronic hyperinsulinemia enhancing growth hormone receptor expression and increasing IGF-1 receptor production, eventually activating IGF-1 receptor signaling pathway, which was known as a promoter of tumor progression [24,25]. This evidence concerns the gene GHR and Hyperinsulinemia.